Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Single Photon Emission Computed Tomography/Computed Tomography (SPECT/CT) Prospective Double-Scanning Study

NCT: NCT07725237 · RECRUITING

NCT IDNCT07725237
StatusRECRUITING
Start Date2026-07-20
Completion2027-02
SponsorGE Healthcare (INDUSTRY)
First posted
Last updated

Brief Summary

The goal of this study is to collect image data for the StarGuide GX Single Photon Emission Computed Tomography/Computed Tomography (SPECT/CT) System in a clinical setting. The StarGuide GX scan will be compared to the participant's clinically indicated SPECT/CT scanner.

Frequently Asked Questions

What is Single Photon Emission Computed Tomography/Computed Tomography (SPECT/CT) Prospective Double-Scanning Study?

Single Photon Emission Computed Tomography/Computed Tomography (SPECT/CT) Prospective Double-Scanning Study is a clinical trial registered under NCT07725237. Current status: RECRUITING.

What is the status of NCT07725237?

The current status of NCT07725237 (Single Photon Emission Computed Tomography/Computed Tomography (SPECT/CT) Prospective Double-Scanning Study) is: RECRUITING.

When did Single Photon Emission Computed Tomography/Computed Tomography (SPECT/CT) Prospective Double-Scanning Study start?

Single Photon Emission Computed Tomography/Computed Tomography (SPECT/CT) Prospective Double-Scanning Study started on 2026-07-20.

Related Devices

K153355Xeleris 4.0 Processing and Review WorkstationGE Healthcare K153402Discovery NM/CT 670 CZTGE Healthcare K160162Voluson P6, Voluson P8GE Healthcare K160182LOGIQ S7 ExpertGE Healthcare K160184Voluson S6, Voluson S8, Voluson S10GE Healthcare

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑